Ben Fidler

With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC

	Profile	Recent Articles on Subject
1	Ben Fidler Pharma Voice	With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC - about 2 months ago With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC - about 2 months ago Wave sees RNA editing validation in early trial results - 2 months ago Pfizer research chief Dolsten to step down, with company at a crossroads - 6 months ago Biotech veteran Art Krieg postpones retirement to build an unorthodox drug startup - 9 months ago Medicare to cover Novo’s obesity drug for some patients - 9 months ago Biotech IPOs heated up to start 2024. Will the surge last? - 10 months ago BioMarin preaches patience amid slow sales for hemophilia gene therapy - 10 months ago AstraZeneca, Daiichi aim for first pan-tumor ADC approval - 11 months ago CRISPR eyes autoimmune disease in revamp of cell therapy plans - about 1 year ago
2	Ned Pagliarulo Pharma Voice	With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC - about 2 months ago With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC - about 2 months ago Wave sees RNA editing validation in early trial results - 2 months ago
3	Gwendolyn Wu Pharma Voice	Biotech IPOs heated up to start 2024. Will the surge last? - 10 months ago